Recent ATYR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:01:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 12:02:37 PM
- aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update • GlobeNewswire Inc. • 05/15/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:17:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:15:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:14:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:10:17 PM
- aTyr Pharma to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/13/2026 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 08:03:51 PM
- aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting • GlobeNewswire Inc. • 05/11/2026 08:01:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/26/2026 08:10:33 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/26/2026 08:09:23 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/26/2026 08:08:09 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/12/2026 08:01:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2026 09:11:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 09:03:40 PM
- aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update • GlobeNewswire Inc. • 03/05/2026 09:01:00 PM
- aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/20/2026 09:01:00 PM
- aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference • GlobeNewswire Inc. • 02/18/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2026 12:17:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2026 12:12:45 AM
- aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis • GlobeNewswire Inc. • 02/03/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 10:46:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 10:40:29 PM
- The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 12/08/2025 02:00:00 PM
